Is HBV prophylaxis required during CLL treatment with ibrutinib?

MeSH terms

• Adenine / analogs & derivatives
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Antiviral Agents / therapeutic use*
• Biomarkers
• Hepatitis B / diagnosis
• Hepatitis B / etiology*
• Hepatitis B / prevention & control*
• Hepatitis B / virology
• Humans
• Leukemia, Lymphocytic, Chronic, B-Cell / complications*
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
• Piperidines
• Pre-Exposure Prophylaxis*
• Protein Kinase Inhibitors / adverse effects*
• Protein Kinase Inhibitors / therapeutic use
• Pyrazoles / adverse effects*
• Pyrazoles / therapeutic use
• Pyrimidines / adverse effects*
• Pyrimidines / therapeutic use
• Viral Load